甲状腺癌患者血清IL8和IL17表达水平及其临床意义.docVIP

  • 11
  • 0
  • 约1.03万字
  • 约 13页
  • 2022-05-17 发布于广东
  • 举报

甲状腺癌患者血清IL8和IL17表达水平及其临床意义.doc

甲状腺癌患者血清IL8和IL17表达水平及其临床意义 目录 TOC \o 1-9 \h \z \u 目录 1 正文 1 文1:甲状腺癌患者血清IL8和IL17表达水平及其临床意义 1 1 资料与方法 3 2 结果 4 3 讨论 4 文2:乙型肝炎后肝硬化患者血清IL┐6IL┐8和TNF┐α水平变化的意义医学论文 6 1对象和方法 8 参考文摘引言: 11 原创性声明(模板) 12 文章致谢(模板) 13 正文 甲状腺癌患者血清IL8和IL17表达水平及其临床意义 文1:甲状腺癌患者血清IL8和IL17表达水平及其临床意义 [Abstract] Objective To study serum IL-8,IL-17 levels and clinical significance in patients with thyroid cancer. Methods From April 2013 to April 2015, 60 cases of thyroid cancer patients were selected as the research object. The level of serum IL-8, IL-17 were deteced by ELISA, and the level of serum IL-8, IL-17 and age, coue of the disease, malignant degree of thyroid carcinoma, pathologic stage, lymphatic metastasis and so on were analyzed by correlation analysis. Results The serum levels of IL-8 and IL-17 in thyroid cancer group were significantly higher than those of patients in the control group(P). With the decrease of differentiated thyroid cancer, serum level of IL-8 and IL-17 were increasing, and the comparison between two groups had statistical difference (P). Serum levels of IL-8, IL-17 were positive correlated with malignant degree of thyroid carcinoma, pathological staging, lymphatic metastasis and so on (P). Conclusion IL-8 and IL-17 show high expression in thyroid cancer patients serum. And they are closely related to thyroid cancer incidence,degree of differentiation and development。 [Key words] Thyroid cancer; IL-8; IL-17; Correlation 甲状腺癌是一种常见的内分泌肿瘤,近年来发病率呈现上升趋势,对患者健康造成严重危害[1],如果能早期诊断出甲状腺癌并尽快开展相应的治疗,就可以有效地提高肿瘤的治疗效果,改善预后。白细胞介素(IL)家族是由免疫细胞、基质细胞等活化后合成并分泌的一类重要细胞因子,主要在炎症反应及免疫反应中起到调控的作用。白细胞介素8(Interleudin-8,IL-8)作为一种趋化因子,能选择性地引导白细胞亚群的定向游走和组织内集聚,不仅与炎症性疾病有关,而且与肿瘤有密切的关系[2]。而IL-17是一种重要的促炎因子,不仅在炎症反应过程中起作用,在肿瘤中也有表达[3-4]。本研究主要通过对甲状腺癌患者及其健康体检者血清进行检测,明确血清IL-8和IL-17的含量,经与临床资料相关性分析后,探讨其与甲状腺癌发生及发展的关系,现报道如下。 1 资料与方法 一般资料 随机选取我院普外科2013年4月~2015年4月期间接受住院治疗的甲状腺癌患者60例,其中男34例,女26例,年龄36~64岁,平均(±)岁,所有病例由我院病理科经病理切片确诊,血液标本均在患者接受手术及放化疗治疗前采集。甲状腺癌患者TNM病理分期依据UICC第6版的分期标准[5],其中Ⅰ期患者18例,Ⅱ期患者2

文档评论(0)

1亿VIP精品文档

相关文档